A Canadian university in July 2016 said that it will conduct the world's first Zika vaccine test on humans. The vaccine that is under development will be tested on humans in the near future. Until now, vaccines have been tested on mice.
Professor Gary Kobinger of the Universite Laval, based in Quebec City, said that they are very proud to be part of the first international team in the world to complete all of the steps in the regulatory process for the test.
He said that development of the Zika vaccine has been authorized by the US Food and Drug Administration and Health Canada.
Kobinger, a doctor of microbiology and professor of medicine at the university, is overseeing the study.
• The disease is caused by a virus transmitted primarily by Aedes mosquitoes.
• People with Zika virus disease can have symptoms including mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or headache. These symptoms normally last for 2-7 days.
• There is scientific consensus that Zika virus is a cause of microcephaly and Guillain-Barré syndrome. Links to other neurological complications are also being investigated.
• The virus is capable of causing serious birth defects and has traveled quickly through Latin America.
• There is no existing treatment or vaccine for it.
• More than a dozen pharmaceutical companies, including France's Sanofi and India's Bharat Biotech, are working on developing a Zika vaccine, according to the World Health Organization.
Now get latest Current Affairs on mobile, Download # 1 Current Affairs App
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.